Patents by Inventor Norimasa Koseki

Norimasa Koseki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED-RELEASE FORMULATION FOR INJECTION
    Publication number: 20190010149
    Abstract: The present invention relates to a composition comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1?R,2?S,3?R,4?S)-2,3-bicyclo[2,2,1]heptanedicarboximide or a pharmaceutically acceptable acid addition salt thereof. In detail, the composition relates to a sustained release formulation for injection which maintains an effective blood level of the above-mentioned compound.
    Type: Application
    Filed: September 12, 2018
    Publication date: January 10, 2019
    Applicant: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Takashi NAKAGAWA, Norimasa Koseki
  • Sustained-release formulation for injection
    Patent number: 9469630
    Abstract: The present invention relates to a composition comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1?R,2?S,3?R,4?S)-2,3-bicyclo[2,2,1]heptanedicarboximide or a pharmaceutically acceptable acid addition salt thereof. In detail, the composition relates to a sustained release formulation for injection which maintains an effective blood level of the above-mentioned compound.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: October 18, 2016
    Assignee: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Takashi Nakagawa, Norimasa Koseki
  • SUSTAINED-RELEASE FORMULATION FOR INJECTION
    Publication number: 20160158228
    Abstract: The present invention relates to a composition comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1?R,2?S,3?R,4?S)-2,3-bicyclo[2,2,1]heptanedicarboximide or a pharmaceutically acceptable acid addition salt thereof. In detail, the composition relates to a sustained release formulation for injection which maintains an effective blood level of the above-mentioned compound.
    Type: Application
    Filed: February 12, 2016
    Publication date: June 9, 2016
    Applicant: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Takashi NAKAGAWA, Norimasa KOSEKI
  • SUSTAINED-RELEASE FORMULATION FOR INJECTION
    Publication number: 20120091022
    Abstract: The present invention relates to a composition comprising N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1?R,2?S,3?R,4?S)-2,3-bicyclo[2,2,1]heptanedicarboximide or a pharmaceutically acceptable acid addition salt thereof. In detail, the composition relates to a sustained release formulation for injection which maintains an effective blood level of the above-mentioned compound.
    Type: Application
    Filed: October 18, 2011
    Publication date: April 19, 2012
    Inventors: Takashi NAKAGAWA, Norimasa Koseki
  • Sustained release formulation
    Patent number: 5922356
    Abstract: The present invention relates to a sustained release formulation used for treatment or prevention of the diseases, which contains a therapeutically effective substance as an active ingredient, collagen as a drug carrier, and glycosaminoglycan as an additive. The formulation allows controlled release of the therapeutically effective substance.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: July 13, 1999
    Assignees: Sumitomo Pharmaceuticals Company, Limited, Koken Co., Ltd.
    Inventors: Norimasa Koseki, Akihiko Sano